Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass of copper complex of [(2,6-difluoroheterocycl-4-yl)amino]hydroxy{[2-hydroxy-3-sulfonato-5-(vinylsulfonyl)phenyl]diazenyl}naphthalene sulfonic acid, dialkali salt and copper complex of [(2,6-difluoroheterocycl-4-yl)amino]-hydroxy{[2-hydroxy-3-sulfonato-5-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl]diazenyl}naphthalene sulfonic acid, trialkali salt
EC number: 479-550-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 Nov 2002 to 2 May 2003
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Target gene:
- Not applicable
- Species / strain / cell type:
- mammalian cell line, other: Chin. Hamster, V79-Zellen
- Details on mammalian cell type (if applicable):
- cell bank of 'Genetic Toxicology', Aventis Pharma Germany GmbH, Pro Tox, cell line V79 of Chinese hamster lung fibroblasts. Cultured in minimal essential medium (MEM) with Earles's salts and L-glutamine
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix; Aroclor induced rat liver
- Test concentrations with justification for top dose:
- First experiment:
Concentration range (without and with metabolic activation):625, 1250 and 2500 µg/ml
Second experiment/part II, without metabolic activation: 250, 500 and 750 µg/ml
Second experiment:
Concentration range in the main test (with metabolic activation): 625, 1250 and 2500 µg/ml
Concentration range in the main test (without metabolic activation): 125, 250 and 500 µg/ml - Vehicle / solvent:
- cell culture medium (MEM)
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- None
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- with metabolic activation
- Positive control substance:
- cyclophosphamide
- Remarks:
- None
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration:
-3h and 20 h (Experiment 1, with and without S9-mix)
- 20 h (Experiment 2, part II, without S9 mix)
- 3 and 28 h (Experiment 2, with s9 mix)
- 28 h (Experiment 2, without S9 mix)
SPINDLE INHIBITOR (cytogenetic assays): Colcemide (approx. 0.05 µg/mL /culture medium)
STAIN (for cytogenetic assays): 2 % (w/v) orcein solution
NUMBER OF REPLICATIONS: Two
NUMBER OF CELLS EVALUATED: 1000 cells of each cell culture
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: Yes - Evaluation criteria:
- The test substance is classified as clastogenic
(a) If it induces a statistically significant increase in the number of phases with aberrations (without gaps) with one or more of the concentrations tested as compared with the solvent controls.
(b) If there is a concentration-related increase in the number of phases with aberrations (Without gaps).
The test substance is classified as non-clastogenic if the tests are negative both with and without metabolic activation. - Statistics:
- The biometry of the results was performed with a one side Fischer's exact test
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- ( 2500 µg/ml)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- other: as specified above
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (>= 250 µg/ml)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: No effects
- Effects of osmolality: No effects
RANGE-FINDING/SCREENING STUDIES:
Evaluation of the solubility of the suspension in cell culture medium showed that 5000 µg/mL was the highest practicable concentration and produced no precipitate which was visible to the naked eye. Microscopical precipitation was observed with all concentrations investigated.
Preliminary toxicity study: Was carried out using a maximum concentration of 5000 µg/mL and a range of lower dose levels down to 625 µg/mL.
COMPARISON WITH HISTORICAL CONTROL DATA: Yes
Observations:
Precipitations with and without S9-mix at all tested
concentrations - Remarks on result:
- other: other: main test 3 and 20 hours
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation
Under the test conditions, the test substance was not clastogenic in the in vitro chromosome aberration assay with V79 Chinese hamster lung cells. - Executive summary:
A study was conducted to investigate the potential of test substance to induce chromosome aberrations in V 79 cells of the Chinese hamster lung in vitro according to OECD Guideline 473, EPA OPPTS 870.5375, EU Method B.10. and Japanese Substances Control Law (JSCL) in compliance with GLP.
Two experiments with duplicate cultures were used for each concentration. The test substance was suspended in the test medium and tested at the following concentrations:
First experiment with 3/20 h treatment time:
without S9-mix: 625, 1250 and 2500 µg/mL
with S9-mix: 625,1250 and 2500 µg/mL
Second experiment with 20 h treatment time:
without S9-mix: 250, 500, and 750 µg/mL
Second experiment 3/28h treatment time with s9 mix: 624, 1250 and 2500 µg/mL
Second experiment 28/28 h treatment time without s9 mix: 1250, 250 and 500 µg/mL
The concentration ranges were based on the results of preliminary testing for solubility and toxicity. In the presence and absence of S9-mix an indication of cytotoxicity as reduction of mitotic index was observed.
Precipitation of the test compound was not visible to the naked eye but was observed in all microscopic determinations with all concentrations investigated.
Appropriate reference mutagens used as positive controls showed a significant increase in chromosome aberrations, thus indicating the sensitivity of the assay, and the efficacy of the S9-mix. No relevant reproducible enhancement of metaphases with aberrations outside the range of the solvent control was found with any of the concentration used with or without metabolic activation.
These data were found statistically significant enhanced in the Fisher's exact-test. Beside this no dose-dependency was observed.
Test substance did not induce chromosome aberrations in V79 Chinese hamster cells, either in the presence or in the absence of a metabolic activation.
Under the test conditions, the test substance was not clastogenic in the in vitro chromosome aberration assay with V79 Chinese hamster lung cells.
Reference
The sensitivity of the test system and efficacy of the S9-mix was demonstrated by the enhanced mutation frequency in the cell cultures treated with the positive control substances.
Mutation results:
In the first and in the second main experiment the mitotic index was reduced (indication of toxicity) after treatment in the absence and the presence of S9-mix.
No relevant reproducible enhancement of metaphases with aberrations outside the range of the solvent control was found with any of the concentrations used, either with or without metabolic activation by S9-mix.Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Ames test
A study was conducted to determine the mutagenic potential of test substance according to OECD Guideline 471 in compliance with GLP. S. typhimurium strains TA 100, TA 1535, TA 1537, TA 98 and TA 102 and Escherichia coli WP2uvrA pKM101 were used in the mutagenicity assay. Control plates without mutagen showed that the number of spontaneous revertant colonies was within the historical control range although slightly higher. All the positive control compounds showed the expected increase in the number of revertant colonies. Toxicity was observed with strain TA 1537 at the highest concentration in the absence and in the presence of metabolic activation. No mutagenicity was observed with or with metabolic activation at any other concentration with any strains. Under the test conditions, the test substance is considered not to be mutagenic in these bacterial test systems in the presence or absence of exogenous metabolic activation.
Chromosomal aberration test
A study was conducted to investigate the potential of test substance to induce chromosome aberrations in V 79 cells of the Chinese hamster lung in vitro according to OECD Guideline 473 in compliance with GLP. Two experiments with duplicate cultures were used for each concentration (up to 2500 µg/ml). Appropriate reference mutagens used as positive controls showed a significant increase in chromosome aberrations. No relevant reproducible enhancement of metaphases with aberrations outside the range of the solvent control was found with any of the concentration used with or without metabolic activation. Under the test conditions, the test substance was not clastogenic in the in vitro chromosome aberration assay with V79 Chinese hamster lung cells.
UDS assay
A study was conducted to investigate unscheduled DNA synthesis (UDS) in mammalian cells in vitro according to OECD 482 and GLP. Primary rat hepatocyte cultures were exposed to a structural analogue of Reactive Red F00-0124 in cell culture medium at concentrations of 100,30, 10, 3, 1, 0.3 and 0.1 ug/ml for 16-20 hours. The test item was tested up to the limit concentration, 5000 ug/ml in a range finding study. However, microscopic examination of the hepatocyte cultures showed dark blue incorporation of the test substance in all hepatocyte nuclei at the concentrations of 5000, 3000, 1000 and 300 ug/ml as a sign of heavy cytotoxicity and a very low survival rate. Therefore these concentrations were excluded from the evaluation of genotoxicity. The positive controls induced the appropriate response indicating the appropriate level of sensitivity. There was no evidence that unscheduled DNA synthesis (as determined by radioactive tracer procedures) was induced indicating the test item is not genotoxic in this in vitro test.
Justification for selection of genetic toxicity endpoint
GLP guideline study
Justification for classification or non-classification
Under the test conditions, the test substance is considered not to be mutagenic in an adequate testing battery in the presence or absence of exogenous metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.